StockData

Adagio Medical vs CVRx

ADGM and CVRX side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ADGM and CVRX compare

CVRx is the larger company, worth 11 times as much as Adagio Medical ($16.3M against $1.5M).

CVRx scores higher on the StockData Score (8 against 2 for Adagio Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricADGMCVRX
Size and price
Market cap$1.5M$16.3M
Share price$1.65$0.611
Change, 1 year110%−93.4%
Change, 5 years−99.4%−95.3%
Beta (5Y)–−0.96
Employees41223
StockData Score
Total score28 (better)
Valuation score13 (better)
Growth score03 (better)
Performance score11
Health score01 (better)
Dividend score00
Valuation
P/S–0.3×
P/B0.1× (better)0.8×
FCF yield−1203%−252% (better)
Fair value–$7.11
Margin of safety–91.4%
Growth
Revenue growth (TTM)–12.0%
Revenue growth, 5Y average–56.4%
Profitability
Gross margin–86.9%
Operating margin–−79.5%
Net margin–−84.9%
FCF margin–−67.1%
Return on equity9.6% (better)−133%
Return on invested capital−314%−293% (better)
Financial health
Debt / equity–2.94
Interest coverage−5.8× (better)−8.1×
Current ratio0.908.04 (better)
Altman Z-score−6.29 (better)−9.29
Piotroski F-score–3
Dividends and buybacks
Buyback yield–−2.9%
Shareholder yield0.00% (better)−2.9%
Ownership
Held by institutions–57.4%
Held by insiders–49.9%
Insider net buying, 12 months$244K$247K (better)
Short interest, % of float–13.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.